The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases

Clinical Nutrition

Volumn 21, Issue 1, 2002, Pages 1-14

  Franssen, F M E ^a   Wouters, E F M ^a   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic disease; Inactivity; Muscle function; Muscle metabolism; Sarcopenia; Semi starvation; Skeletal muscle

Indexed keywords

ADULT; AGING; ANOREXIA NERVOSA; ARTICLE; CATABOLISM; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENERGY METABOLISM; EXERCISE TOLERANCE; FATIGUE; HEALTH STATUS; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMOBILIZATION; MORPHOLOGY; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE WEAKNESS; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; SKELETAL MUSCLE; STARVATION; SYMPTOM;

EID: 0036206146     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2001.0485     Document Type: Review

References (124)

1. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: Underlying mechanisms and therapy perspectives
2. Introduction to in vivo 31P magnetic resonance spectroscopy of (human) skeletal muscle
3. Structural and functional changes in skeletal muscle in anorexia nervosa
4. A comparison between muscle function and body composition in anorexia nervosa: The effect of refeeding
5. Metabolic abnormalities associated with skeletal myopathy in severe anorexia nervosa
6. Physical complications in anorexia nervosa. Haematological and neuromuscular changes in 12 patients
7. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease
8. Body composition changes in anorexia nervosa
9. Changes in skeletal muscles of young women with anorexia nervosa. An enzyme histochemical study
10. Skeletal muscle fibre types and sizes in anorexia nervosa patients
11. Metabolic and structural changes in skeletal muscle during hypocaloric dieting
12. 31P-nuclear magnetic resonance studies of bioenergetic changes in skeletal muscle in malnourished human adults
13. Muscular atrophy following immobilization. A review
14. Changes in muscle function in response to 10 days of lower limb unloading in humans
15. Effect of short-term unweighting on human skeletal muscle strength and size
16. Effects of immobilization on electromyogram power spectrum changes during fatigue
17. Soft tissue composition, quadriceps strength, bone quality and bone mass in rheumatoid arthritis
18. Changes in musculoskeletal structure and function with prolonged bed rest
19. Skeletal muscle responses to lower limb suspension in humans
20. Surface electromyogram power spectrum changes in human leg muscles following 4 weeks of simulated microgravity
21. Bed rest induces neural and contractile adaptations in triceps surae
22. Structural and metabolic characteristics of human skeletal muscle following 30 days of simulated microgravity
23. Adaptive changes in work capacity, skeletal muscle capillarization and enzyme levels during training and detraining
24. Lower limb skeletal muscle function after 6 wk of bed rest
25. Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristic in man
26. Myosin heavy chain isoform expression following reduced neuromuscular activity: Potential regulatory mechanisms
27. Ageing alters the myosin heavy chain composition of single fibres from human skeletal muscle
28. Time course of changes in human skeletal muscle succinate dehydrogenase and cytochrome oxidase activities and maximal oxygen uptake with physical activity and inactivity
29. Increase in myoglobin content and decrease in oxidative enzyme activities by leg muscle immobilization in man
30. Longitudinal study of skeletal muscle adaptations during immobilization and rehabilitation
31. Humoral mediation of changing body composition during aging and chronic inflammation
32. Aging and muscle function
33. Muscle strength and speed of movement in relation to age and muscle morphology
34. Isometric intermittent endurance of four muscle groups in men aged 20-74 yr
35. Isometric muscle strength and muscular endurance in normal persons aged between 17 and 70 years
36. Changes in skeletal muscle with aging: Effects of exercise training
37. Sarcopenia, hypermetabolism, and aging
38. What is sarcopenia?
39. Human aging, muscle mass, and fiber type composition
40. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men
41. Function, morphology and protein expression of ageing skeletal muscle: A cross-sectional study of elderly men with different training backgrounds
42. Histochemical and ultrastructural aspects of m. vastus lateralis in sedentary old people (age, 65-89 years)
43. Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22-65 years
44. Morphology and enzymatic capacity in arm and leg muscles in 78-81 year old men and women
45. Muscle morphology, enzymatic activity, and muscle strength in elderly men: A follow-up study
46. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women
47. Compensatory muscle fiber hypertrophy in elderly men
48. Skeletal muscle metabolism and ultrastructure in relation to age in sedentary men
49. Automatic morphometric analysis of skeletal muscle fibers in the aging man
50. Evaluation of muscle oxidative potential by 31P-MRS during incremental exercise in old and young humans
51. Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles
52. 2 kinetics in old and young individuals
53. Aging of skeletal muscle: A 12-yr longitudinal study
54. Examination of the energetics of aging skeletal muscle using nuclear magnetic resonance
55. Peripheral muscle weakness contributes to exercise limitation in COPD
56. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders
57. Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight
58. Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: The effects of oxygen breathing
59. Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation
60. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients
61. Abnormalities of skeletal muscle in patients with chronic heart failure
62. Muscular performance in heart failure
63. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance
64. Direct measurement of skeletal muscle fatigue in patients with chronic heart failure
65. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure
66. Proximal muscle weakness in uremia. Case reports and review of the literature
67. Altered muscle energy metabolism in post-absorptive patients with chronic renal failure
68. Isokinetic muscle strength predicts maximum exercise tolerance in renal patients on chronic hemodialysis
69. Physiological abnormalities of skeletal muscle in dialysis patients
70. Skeletal muscle limits the exercise tolerance of renal transplant recipients: Effects of a graded exercise training program
71. Myoneuropathy in patients with chronic renal failure treated with hemodialysis (HD) and intermittent peritoneal dialysis (IPD). I. Evaluation of myoelectric activity of selected skeletal muscles in failure treated with hemodialysis and intermittent peritoneal dialysis
72. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease
73. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure
74. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure
75. Effects of renal failure on skeletal muscle
76. Chronic obstructive pulmonary disease: Capillarity and fiber-type characteristics of skeletal muscle
77. Skeletal muscle alterations in patients with chronic heart failure
78. Skeletal muscle fiber composition and capillarization in patients with chronic heart failure: Relation to exercise capacity and central hemodynamics
79. Alterations of skeletal muscle in chronic heart failure
80. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease
81. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD
82. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD
83. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation
84. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease
85. Skeletal muscle metabolism during exercise in patients with chronic heart failure
86. Effects of chronic renal failure on enzymes of energy metabolism in individual human muscle fibers
87. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia
88. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease
89. Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure
90. Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS
91. 13P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure
92. 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment
93. Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure
94. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance
95. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance
96. Skeletal muscle metabolism in patients with congestive heart failure: Relation to clinical severity and blood flow
97. Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure
98. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure
99. 31P NMR spectroscopy investigation of muscle metabolism in hemodialysis patients
100. 31P magnetic resonance spectroscopy investigation of skeletal muscle metabolism in uraemic patients
101. Impaired muscle energy metabolism in uremia as monitored by 31P-NMR
102. Effect of anaemia correction on skeletal muscle metabolism in patients with end-stage renal disease: 31P magnetic resonance spectroscopy assessment
103. 31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients
104. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease
105. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure
106. Cardiac cachexia: A syndrome with impaired survival and immune and neuroendocrine activation
107. Nutritional considerations in the treatment of chronic obstructive pulmonary disease
108. Whole body and regional body composition in patients with chronic renal failure
109. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
110. Effect of unsupported arm exercise on ventilatory muscle recruitment in patients with severe chronic airflow obstruction
111. Metabolic and ventilatory response pattern to arm elevation in patients with COPD and healthy age-matched subjects
112. The neuromuscular system in patients with anorexia nervosa: Electrophysiological and histologic studies
113. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: Differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis
114. Effect of spaceflight on the functional, biochemical, and metabolic properties of skeletal muscle
115. Effects of disuse on the structure and function of skeletal muscle
116. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure
117. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance
118. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD
119. Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure
120. Apoptosis in the skeletal muscle of patients with heart failure: Investigation of clinical and biochemical changes
121. The effects of exercise training on muscle atrophy in haemodialysis patients
122. Morphologic features of the myopathy associated with chronic renal failure
123. Muscle metabolic status in patients with server COPD with and without long-term prednisolone